Cargando…
Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer’s Disease
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the leading cause of dementia. The disease progression is associated with the build-up of amyloid plaques and neurofibrillary tangles in the brain. However, besides the well-defined lesions, the AD-related pathology includes neuroi...
Autores principales: | Polis, Baruh, Gurevich, Vyacheslav, Assa, Michael, Samson, Abraham O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770953/ https://www.ncbi.nlm.nih.gov/pubmed/31540372 http://dx.doi.org/10.3390/ijms20184616 |
Ejemplares similares
-
L-Norvaline, a new therapeutic agent against Alzheimer’s disease
por: Polis, Baruh, et al.
Publicado: (2019) -
Reports of L-Norvaline Toxicity in Humans May Be Greatly Overstated
por: Polis, Baruh, et al.
Publicado: (2019) -
L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer’s Disease
por: Polis, Baruh, et al.
Publicado: (2018) -
Norvaline Reduces Blood Pressure and Induces Diuresis in Rats with Inherited Stress-Induced Arterial Hypertension
por: Gilinsky, Michael A., et al.
Publicado: (2020) -
Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer’s Disease Mice
por: Polis, Baruh, et al.
Publicado: (2020)